GO
Loading...

Sunesis Pharmaceuticals Inc

More

  • "Markets are reflecting nervousness around third-quarter earnings given the strong dollar and a very weak macro environment in Europe," said Jim Russell, senior equity strategist for U.S. Hewlett-Packard posted the S&P 500' s largest gains, up 4.7 percent to $36.87 after it said it would split into two listed companies and eliminate another 5,000 jobs.

  • Oct 6- Sunesis Pharmaceuticals Inc said its experimental cancer drug did not meet the main goal in a late-stage trial in patients with refractory acute myeloid leukemia, a type of bone marrow cancer. The American Cancer Society estimates there will be about 18,860 new cases of AML in the Unites States this year 2014.. The company said it plans to meet the U.S. Food...

  • Sunesis's cancer drug fails late-stage trial Monday, 6 Oct 2014 | 7:11 AM ET

    Oct 6- Sunesis Pharmaceuticals said its experimental cancer drug did not meet its main goal in a late-stage trial in patients with refractory acute myeloid leukemia, a type of bone marrow cancer. Shares of the company slumped 55 percent to $3 in premarket trading on Monday. The overall survival rate of patients given the drug, vosaroxin, was not statistically...

  • Midday movers: Exxon Mobil, Merck, Twitter & More Thursday, 12 Jun 2014 | 12:20 PM ET
    Traders on the floor of the New York Stock Exchange.

    Some of Thursday's midday movers:

  • TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.

  • Movers roundup: Informatica, Sunesis Friday, 5 Oct 2012 | 5:38 PM ET

    Among the stock activity stories for Friday, Oct. 5, from AP Business News:. _ Shares of business software maker Informatica Corp. made a small rebound after losing more than 20 percent of their value a day earlier following the company's disappointing third-quarter forecast.

  • Sunesis Pharma rises on cancer drug study details Friday, 5 Oct 2012 | 4:56 PM ET

    NEW YORK-- Shares of Sunesis Pharmaceuticals Inc. rose Friday after the company discussed plans for an upcoming trial of its cancer drug vosaroxin. THE SPARK: Sunesis held a conference call with investors and analysts Thursday and detailed its studies on vosaroxin, an experimental treatment for acute myeloid leukemia.

  • The Nasdaq Composite Index increased 1.18 points, or 0.04 percent, to 3,150.64. **PRIMERO MINING CORP, $7.16, up 32.6 pct. **FLEETMATICS GROUP PLC, $22.98, up 35.2 pct.

  • The Nasdaq Composite Index added 8.92 points, or 0.28 percent, to 3,158.38. **PRIMERO MINING CORP, $7.70, up 42.75 pct. The ruling confirms that Primero can record silver revenue and taxes from its San Dimas gold mine in Durango state at the realized silver price rather than the spot price.

  • Oct 5- Sunesis Pharmaceuticals Inc:. *Roth Capital raises Sunesis Pharmaceuticals Inc price target to $12. Reuters Station users, click. 1568.

  • Oct 5- Sunesis Pharmaceuticals Inc:. *RBC raises Sunesis Pharmaceuticals Inc price target to $9 from $7;. Reuters Station users, click. 1568.

  • There is a great chance that Sirius XM Radio’s stock will hit $1.65 within the next several sessions — in other words, this is bound to get worse before it gets better.

  • 5 Stocks Under $10 Poised for Breakouts Thursday, 17 May 2012 | 12:50 PM ET

    Here’s a look at several under-$10 stocks that look poised to potentially trade higher from current levels.